Abstract
A study was conducted to evaluate the effects of a new, highly selective plasma kallikrein inhibitor, PKSI-527, on collagen-induced arthritis (CIA) in mice. PKSI-527 or indomethacin was administered daily intraperitoneally from day 20 postimmunization. Clinical evaluation was performed, and two of the components of the kallikrein-kinin system, high-molecular-weight (HMW) kininogen and plasma prekallikrein, were assyed. PKSI-527, as well as indomethacin, reduced the severity of arthritis significantly. PKSI-527, but not indomethacin, restored consumed components of the kallikrein-kinin system. These results suggest that PKSI-527 suppresses CIA by modifying the kallikrein-kinin system and PKSI-527 as a synthetic plasma kallikrein inhibitor would be a valuable tool to study the mechanism of inflammation of arthritic diseases.
Similar content being viewed by others
References
D. Regoli,Kinins. Br. Med. Bull.43, 270–284 (1987).
R. Holmdahl, M. E. Andersson, T. J. Goldschmidt, L. Jansson, M. Karlsson, V. Malmström and J. Mo,Collagen induced arthritis as an experimental model for rheumatoid arthritis. APMIS97, 575–584 (1989).
J. S. Courtenay, M. J. Dallman, A. D. Dayan, A. Martin and B. Mosedale,Immunization against heterologous type II collagen induces arthritis in mice. Nature283, 666–668 (1980).
J. M. Stuart, W. C. Watson and A. H. Kang,Collagen autoimmunity and arthritis. FASEB J.2, 2950–2956 (1988).
P. H. Wooley,Collagen-induced arthritis in the mouse. Methods Enzymol.162, 361–373 (1988).
K. Takagishi, N. Kaibara, T. Hotokebuchi, C. Arita, M. Morinaga and K. arai,Effects of cyclosporin on collagen induced arthritis in mice. Ann. Rheum. Dis.45, 339–344 (1986).
P. H. Wooley, J. D. Whalen, J. L. Zimmerman and T. M. Champion,The effect of etodolac on type II collageninduced arthritis in mice. Agents and Actions21, 244–246 (1987).
J. Björk and S. Kleinau,Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen induced arthritis model in mice. Agents and Actions27, 319–321 (1989).
D. F. Carmichael, G. P. Stricklin and J. M. Stuart,Systemic administration of TIMP in the treatment of collagen-induced arthritis in mice. Agents and Actions27, 378–379 (1989).
K. Takagishi, M. Yamamoto, A. Nishimura, G. Yamasaki, N. Kanazawa, T. Hotokebuchi and N. Kaibara,Effects of FK-506 on collagen arthritis in mice. Transplant. Proc.21, 1053–1055 (1989).
J. A. Wolos, D. E. Logan and T. L. Bowlin,Methylacetylenic putrescine (MAP), an inhibitor of polyamine biosynthesis, prevents the development of collageninduced arthritis. Cell. Immunol.125, 498–507 (1990).
H. Nakajima, H. Takamori, Y. Hiyama and W. Tsukada,The effect of treatment with inerferon-gamma on type II collagen-induced arthritis. Clin. Exp. Immunol.81, 441–445 (1990).
K. Takagishi, M. Yamamoto, K. Maeda, A. Nishimura, K. Yonemoto, T. Hotokebuchi and N. Kaibara,Effects of deoxyspergualin on collagen arthritis in mice. Clin. Immunol. Immunopathol.56, 81–87 (1990).
A. Ueno, S. Oh-ishi, T. Kitagawa and M. Katori,Enzyme immunoassay of bradykinin using β-D-galactosidase as a labeling enzyme. Biochem. Pharmacol.30, 1659–1664 (1981).
K. Wanaka, S. Okamoto, M. Bohgaki, A. Hijikata-Okunomiya, T. Naito and Y. Okada,Effect of a highly selective plasma-kallikrein synthetic inhibitor on contact activation relating to kinin generation, coagulation and fibrinolysis. Thromb. Res.57, 889–895 (1990).
K. Ikeda, K. Tanaka and M. Katori,Potentiation of bradykinin-induced vascular permeability increase by prostaglandin E 2 and arachidonic acid in rabbit skin. Prostaglandins10, 747–758 (1975).
G. S. Basran, J. Morley, W. Paul and M. Turner-Warwick,Evidence in man of synergistic interaction between putative mediators of acute inflammation and asthma. Lancet1, 935–937 (1982).
D. Regoli,Neurohumoral regulation of precapillary vessels: The kallikrein-kinin system. J. Cardiovasc. Pharmacol.6 (Suppl 2). 401–412 (1984).
F. Guzman, C. Braun and R. K. S. Lim,Visceral pain and the pseudoaffective response to intra-arterial injections of bradykinin and other algesic agents. Arch. Int. Pharmacodyn.136, 353–384 (1962).
L. Stoppini, F. Barja, R. Mathison and J. Baertschi,Spinal substance P transmits bradykinin but not osmotic stimuli from hepatic portal vein to hypothalamus in rat. Neuroscience11, 903–912 (1984).
K. M. Hargreaves, E. S. Troullos, R. A. Dionne, E. A. Schmidt, S. C. Schafer and J. L. Joris,Bradykinin is increased during acute and chronic inflammation: Therapeutic implications. Clin. Pharmacol. Ther.44, 613–621 (1988).
H. Fritz and G. Wunderer,Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Drug Res.33, 479–494 (1983).
T. Aoyama, Y. Ino, M. Ozeki, M. Oda, T. Sato, Y. Koshiyama, S. Suzuki and M. Fujita,Pharmacological studies of FUT-175, nafamstat mesilate: I. Inhibition of protease activity in in vitro and in vivo experiments. Jap. J. Pharmacol.35, 203–227 (1984).
J. A. Salmon and G. A. Higgs,Prostaglandins and leukotrienes as inflammatory mediators. Br. Med. Bull.43, 285–296 (1987).
K. Phadke, R. L. Fouts, J. E. Parrish and L. D. Butler,Evaluation of the effects of various anti-arthritic drugs on type II collagen-induced mouse arthritis model. Immunopharmacology10, 51–60 (1985).
C. Rordorf, A. Pataki, V. Nogues, F. Schlager, U. Feige and M. Glatt,Arthritis in MRL/lpr mice and in collagen II sensitized DBA-1 mice and their use in pharmacology. Int. J. Tissue. React.9, 341–347 (1987).
W. Paska, K. J. McDonald and M. Croft,Studies on type II collagen induced arthritis in mice. Agents and Actions18, 413–420 (1986).
D. E. Griswold, L. M. Hillegass, P. C. Meunier, M. J. DiMartino and N. Hanna,Effect of inhibitors of eicosanoid metabolism in murine collagen-induced arthritis. Arth. Rheum.31, 1406–1412 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fujimori, Y., Nakamura, T., Shimizu, K. et al. Effects of a highly selective plasma kallikrein inhibitor on collagen-induced arthritis in mice. Agents and Actions 39, 42–48 (1993). https://doi.org/10.1007/BF01975713
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01975713